- Home
- RPD vs ENOV Comparison
RPD vs ENOV Comparison
Compare RPD & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPD
- ENOV
- Stock Information
- Founded
- RPD 2000
- ENOV 1995
- Country
- RPD United States
- ENOV United States
- Employees
- RPD N/A
- ENOV N/A
- Industry
- RPD Computer Software: Prepackaged Software
- ENOV Fluid Controls
- Sector
- RPD Technology
- ENOV Industrials
- Exchange
- RPD Nasdaq
- ENOV Nasdaq
- Market Cap
- RPD 2.4B
- ENOV 2.4B
- IPO Year
- RPD 2015
- ENOV 2008
- Fundamental
- Price
- RPD $38.84
- ENOV $46.59
- Analyst Decision
- RPD Buy
- ENOV Strong Buy
- Analyst Count
- RPD 18
- ENOV 8
- Target Price
- RPD $44.71
- ENOV $67.00
- AVG Volume (30 Days)
- RPD 671.1K
- ENOV 1.2M
- Earning Date
- RPD 02-12-2025
- ENOV 02-20-2025
- Dividend Yield
- RPD N/A
- ENOV N/A
- EPS Growth
- RPD N/A
- ENOV N/A
- EPS
- RPD 0.66
- ENOV N/A
- Revenue
- RPD $833,014,000.00
- ENOV $2,001,668,000.00
- Revenue This Year
- RPD $9.10
- ENOV $25.59
- Revenue Next Year
- RPD $5.35
- ENOV $5.74
- P/E Ratio
- RPD $59.12
- ENOV N/A
- Revenue Growth
- RPD 10.05
- ENOV 20.52
- 52 Week Low
- RPD $32.95
- ENOV $38.27
- 52 Week High
- RPD $61.88
- ENOV $65.03
- Technical
- Relative Strength Index (RSI)
- RPD 42.30
- ENOV 58.02
- Support Level
- RPD $37.57
- ENOV $45.02
- Resistance Level
- RPD $40.42
- ENOV $46.34
- Average True Range (ATR)
- RPD 1.20
- ENOV 1.55
- MACD
- RPD 0.00
- ENOV 0.27
- Stochastic Oscillator
- RPD 33.33
- ENOV 76.36
About RPD Rapid7 Inc.
Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.
About ENOV Enovis Corporation
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.